U.S. markets closed
  • S&P Futures

    4,260.75
    +6.00 (+0.14%)
     
  • Dow Futures

    34,396.00
    +15.00 (+0.04%)
     
  • Nasdaq Futures

    14,150.75
    +26.00 (+0.18%)
     
  • Russell 2000 Futures

    2,324.40
    +0.80 (+0.03%)
     
  • Crude Oil

    71.33
    +0.45 (+0.63%)
     
  • Gold

    1,863.10
    -2.80 (-0.15%)
     
  • Silver

    27.75
    -0.28 (-1.01%)
     
  • EUR/USD

    1.2120
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    1.5010
    +0.0390 (+2.67%)
     
  • Vix

    16.39
    +0.74 (+4.73%)
     
  • GBP/USD

    1.4105
    -0.0003 (-0.02%)
     
  • USD/JPY

    110.0600
    -0.0010 (-0.00%)
     
  • BTC-USD

    40,146.24
    +451.29 (+1.14%)
     
  • CMC Crypto 200

    1,004.69
    +35.85 (+3.70%)
     
  • FTSE 100

    7,146.68
    +12.62 (+0.18%)
     
  • Nikkei 225

    29,438.53
    +276.73 (+0.95%)
     

EFPIA Warns of Fake Jabs If Vaccine Patents Are Waived

May.07 -- The European Federation of Pharmaceutical Industries and Associations says that President Joe Biden's support for international talks on waiving patent protections for Covid-19 vaccines could result in a fall in quality if raw materials are diverted away from approved production facilities. "If you suddenly have a diversion towards other manufacturing sites that maybe are less efficient, less productive, means that the quality is less good, maybe you suddenly have counterfeits," Nathalie Moll, EFPIA's director general, said on Bloomberg Television.